GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Wuzhong Pharmaceutical Development Co Ltd (SHSE:600200) » Definitions » Total Equity

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Total Equity : ¥1,767 Mil (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jiangsu Wuzhong Pharmaceutical Development Co Total Equity?

Jiangsu Wuzhong Pharmaceutical Development Co's total equity for the quarter that ended in Mar. 2024 was ¥1,767 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Jiangsu Wuzhong Pharmaceutical Development Co Total Equity Historical Data

The historical data trend for Jiangsu Wuzhong Pharmaceutical Development Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Wuzhong Pharmaceutical Development Co Total Equity Chart

Jiangsu Wuzhong Pharmaceutical Development Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,363.31 1,851.93 1,876.93 1,823.52 1,761.44

Jiangsu Wuzhong Pharmaceutical Development Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,854.23 1,859.50 1,844.21 1,761.44 1,767.28

Jiangsu Wuzhong Pharmaceutical Development Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Jiangsu Wuzhong Pharmaceutical Development Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=4326.878-2565.434
=1,761

Jiangsu Wuzhong Pharmaceutical Development Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=4417.295-2650.013
=1,767

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Wuzhong Pharmaceutical Development Co Total Equity Related Terms

Thank you for viewing the detailed overview of Jiangsu Wuzhong Pharmaceutical Development Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Business Description

Traded in Other Exchanges
N/A
Address
110 North Road, Soochow 7,8,10 Bank of China Building, Suzhou, Jiangsu, CHN, 215128
Jiangsu Wuzhong Industrial Co Ltd is a China-based company. It develops, produces and sells medicines while engages in real estate development.
Executives
Xu Liang Zhi senior management
Sun Jian Ying Supervisors
Zhong Yao Wen Supervisors
Cheng Xi senior management
Wu Jian Min Supervisors
Zhao Wei Yi Director
Jin Li Director
Sun Tian Jiang senior management
Zhu Ju Fang senior management
Yao Jian Lin Director
Jin Jian Ping Supervisors
Li Gui Zhi Supervisors
Luo Qin Supervisors
Xia Jian Ping Director
Zhong Shen Zheng Director

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Headlines

No Headlines